By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent and Chungnam National University today announced a collaboration targeting glycomics.

Under the terms of the deal, the partners will develop new applications, methods, technologies, and software tools for glycan analysis. The South Korean university hopes to identify and develop biomarkers for diseases, such as cancer, resulting in the development of therapeutic antibody products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.